Kennedy D O, Scholey A B, Wesnes K A
Division of Psychology, University of Northumbria, Newcastle upon Tyne, UK.
Nutr Neurosci. 2001;4(5):399-412. doi: 10.1080/1028415x.2001.11747376.
We have previously shown differential cognitive improvements following single doses of Ginkgo biloba and of Ginseng. There is also evidence that chronic administration of a combination of standardised extracts of Ginkgo biloba and Panax ginseng may improve aspects of cognitive performance both in pathological populations and the healthy middle aged. No investigation has thus far looked either at the cognitive effects of single doses of such a combination, nor the effects of the combination on healthy young volunteers. The present study investigated whether acute administration of a combination of standardised extracts of Ginkgo biloba (GK501, Pharmaton SA) and Ginseng (G115, Pharmaton SA) had any consistent effect on mood and aspects of cognitive performance ("quality of memory", "secondary memory", "working memory", "speed of memory", "quality of attention" and "speed of attention") that can be derived by factor analysis of the cognitive drug research computerised assessment battery. The study followed a placebo-controlled, double blind, balanced, crossover design. Twenty healthy young adult volunteers received 320, 640, and 960 mg of the combination, and a matching placebo, in an order dictated by random allocation to a Latin square, and with a seven-day wash-out period between treatments. Following a baseline cognitive assessment, further test sessions took place 1, 2.5,4 and 6 h after the day's treatment. The most striking result was a dose-dependent improvement in performance on the "quality of memory" factor for the highest dose. Further analysis revealed that this effect was differentially targeted at the secondary memory rather than the working memory component. There was also a dose dependent decrement in performance of the "speed of attention" factor for both the 320 and 640 mg doses. These results are discussed in the context of previous findings within this series of studies.
我们之前已经表明,单次服用银杏叶提取物和人参后认知功能有不同程度的改善。也有证据表明,长期服用银杏叶标准化提取物和人参的组合可能会改善病理人群和健康中年人的认知表现。迄今为止,尚无研究考察过单次服用这种组合的认知效果,也没有考察过该组合对健康年轻志愿者的影响。本研究调查了急性服用银杏叶标准化提取物(GK501,法玛通公司)和人参标准化提取物(G115,法玛通公司)的组合是否对情绪以及认知表现的各个方面(“记忆质量”、“次级记忆”、“工作记忆”、“记忆速度”、“注意力质量”和“注意力速度”)有任何一致的影响,这些方面可通过对认知药物研究计算机化评估电池进行因子分析得出。该研究采用了安慰剂对照、双盲、平衡、交叉设计。20名健康的年轻成年志愿者按照随机分配到拉丁方的顺序,接受320毫克、640毫克和960毫克的该组合以及匹配的安慰剂,且每次治疗之间有7天的洗脱期。在进行基线认知评估后,在当天治疗后的1小时、2.5小时、4小时和6小时进行进一步的测试。最显著的结果是,最高剂量组在“记忆质量”因子上的表现呈剂量依赖性改善。进一步分析表明,这种影响主要针对次级记忆而非工作记忆成分。此外,320毫克和640毫克剂量组在“注意力速度”因子上的表现也呈剂量依赖性下降。将在本系列研究的先前发现背景下讨论这些结果。